RAMANATHAN MUTHAIAH: Open Payments
NPI 1356367734 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$308 in 15 payments from 8 companies in 2025. Trend: 2023 $172 · 2024 $136 · 2025 $308
Food & beverage: $308
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $77 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Boston Scientific Corporation | 3 | $53 |
| Amgen Inc. | 2 | $45 |
| ABBVIE INC. | 1 | $26 |
| Intra-Sana Laboratories | 1 | $20 |
| Lilly USA, LLC | 1 | $15 |
| Exact Sciences Corporation | 1 | $13 |
Products named: CAPLYTA, General - Pain Management, OTEZLA, BREZTRI, VRAYLAR, AIRSUPRA, RELTONE 200 MG, MOUNJARO.
Industry payments across NV — which companies pay providers there.
